Wonderful news!
Congratulations, @RaceOncology and @Davisite!
RAC now has a clinic-ready drug, and what a good drug it is!
Fingers crossed the bureaucrats dealing with the ethics application and governance approvals can step out of character and be super-speedy with their pen signing.
Next big milestone: first patient dosed…..
One reason I am excited about bisantrene now being clinic-ready in a patient-friendly formulation is that it may attract a flood of investigator-led study requests…. and, of course, lots more curiosity from big pharma with acquisition ambitions.
Ann: RC220 GLP Non-clinical Toxicology Program Successful, page-13
-
- There are more pages in this discussion • 68 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.75 |
Change
0.125(7.69%) |
Mkt cap ! $285.4M | |||
| Open | High | Low | Value | Volume |
| $1.65 | $1.75 | $1.65 | $103.9K | 62.07K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1756 | $1.71 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.75 | 952 | 2 |
View Market Depth
| Last trade - 11.49am 12/09/2024 (20 minute delay) ? |
| RAC (ASX) Chart |